Silk Road Medical, Inc. (SILK): Price and Financial Metrics
SILK Price/Volume Stats
| Current price | $17.32 | 52-week high | $46.57 |
| Prev. close | $17.42 | 52-week low | $6.08 |
| Day low | $17.09 | Volume | 373,000 |
| Day high | $17.83 | Avg. volume | 798,345 |
| 50-day MA | $17.38 | Dividend yield | N/A |
| 200-day MA | $15.37 | Market Cap | 678.51M |
SILK Stock Price Chart Interactive Chart >
Silk Road Medical, Inc. (SILK) Company Bio
Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm's devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin. Its products include ENROUTE Transcarotid Neuroprotection & Stent System. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
Latest SILK News From Around the Web
Below are the latest news stories about SILK ROAD MEDICAL INC that investors may wish to consider to help them evaluate SILK as an investment opportunity.
Here’s Why Silk Road Medical (SILK) Came Under Pressure Despite 37% GrowthMeridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned -10.24% (net) in the third quarter compared to the Russell 2000 Growth Index’s -7.32% return. Overall, underperformance during the quarter resulted from the market’s muted or […] |
Here’s Why Silk Road Medical (SILK) Detracted in Q3Wasatch Global Investors, an investment management firm, released its “Wasatch Small Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Stocks fell broadly in the quarter as investors worried about the consequences of rising interest rates and a possible recession. During the quarter, the strategy declined but […] |
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceSUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 10, 2024 at 1:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s we |
15 Best Falling Stocks To Buy NowIn this piece, we will take a look at the 15 best falling stocks to buy now. If you want to skip our overview of the current stock market environment and our coverage of the latest stock market news, then you can skip ahead to 5 Best Falling Stocks To Buy Now. With 2023 coming […] |
Silk Road Medical, Inc (NASDAQ:SILK) Q3 2023 Earnings Call TranscriptSilk Road Medical, Inc (NASDAQ:SILK) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Good day and thank you for standing by. Welcome to the Silk Road Medical Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please […] |
SILK Price Returns
| 1-mo | -8.31% |
| 3-mo | 16.63% |
| 6-mo | 174.92% |
| 1-year | -62.46% |
| 3-year | -69.38% |
| 5-year | -50.51% |
| YTD | 41.16% |
| 2023 | -76.78% |
| 2022 | 24.03% |
| 2021 | -32.34% |
| 2020 | 55.97% |
| 2019 | N/A |
Loading social stream, please wait...